---
title: "Tasosartan - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db01349-mesh-d006973-1.html
toc: false 
---


Path ID: `DB01349_MESH_D006973_1`
{% include image.html url="images/db01349-mesh-d006973-1.png" file="db01349-mesh-d006973-1.png" alt="db01349-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C086167">MESH:C086167 </a> | tasosartan | Drug |
| <a href="https://identifiers.org/MESH:C415846">MESH:C415846 </a> | enoltasosartan | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P30556">UniProt:P30556 </a> | Type-1 angiotensin II receptor | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-2022377">reactome:R-HSA-2022377 </a> | Renin-angiotensin-aldosterone system | Pathway |
| <a href="https://identifiers.org/GO:0003092">GO:0003092 </a> | renal water retention | BiologicalProcess |
| <a href="https://identifiers.org/GO:0070294">GO:0070294 </a> | renal sodium ion absorption | BiologicalProcess |
| <a href="https://identifiers.org/HP:0032263">HP:0032263 </a> | Increased blood pressure | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | Vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/GO:0035932">GO:0035932 </a> | Aldosterone secretion | BiologicalProcess |
| <a href="https://identifiers.org/GO:0003095">GO:0003095 </a> | Pressure natriuresis | BiologicalProcess |
| <a href="https://identifiers.org/UBERON:0001235">UBERON:0001235 </a> | Adrenal cortex | GrossAnatomicalStructure |
| <a href="https://identifiers.org/HP:0000822">HP:0000822 </a> | Blood pressure | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D006973">MESH:D006973 </a> | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tasosartan | HAS METABOLITE | Enoltasosartan |
| Enoltasosartan | NEGATIVELY REGULATES | Type-1 Angiotensin Ii Receptor |
| Type-1 Angiotensin Ii Receptor | POSITIVELY REGULATES | Renin-Angiotensin-Aldosterone System |
| Renin-Angiotensin-Aldosterone System | POSITIVELY CORRELATED WITH | Vasoconstriction |
| Renin-Angiotensin-Aldosterone System | POSITIVELY REGULATES | Renal Water Retention |
| Renin-Angiotensin-Aldosterone System | POSITIVELY REGULATES | Renal Sodium Ion Absorption |
| Renal Sodium Ion Absorption | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Renal Water Retention | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Increased Blood Pressure | AFFECTS RISK FOR | Hypertensive Disorder |
| Type-1 Angiotensin Ii Receptor | POSITIVELY REGULATES | Aldosterone Secretion |
| Aldosterone Secretion | LOCATED IN | Adrenal Cortex |
| Adrenal Cortex | POSITIVELY REGULATES | Pressure Natriuresis |
| Pressure Natriuresis | POSITIVELY REGULATES | Blood Pressure |
| Blood Pressure | MANIFESTATION OF | Hypertensive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01349](https://go.drugbank.com/drugs/DB01349)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL432162/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL432162/)
  - [https://pubmed.ncbi.nlm.nih.gov/11046101/](https://pubmed.ncbi.nlm.nih.gov/11046101/)
  - [https://pubmed.ncbi.nlm.nih.gov/9784100/](https://pubmed.ncbi.nlm.nih.gov/9784100/)
